Varex Imaging (NASDAQ:VREX) Stock Rating Lowered by Wall Street Zen

Varex Imaging (NASDAQ:VREX) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report released on Saturday.

Several other analysts also recently commented on the stock. Jefferies Financial Group reaffirmed a “hold” rating and issued a $14.50 price objective on shares of Varex Imaging in a report on Monday, February 2nd. B. Riley Financial reaffirmed a “buy” rating on shares of Varex Imaging in a report on Thursday. Oppenheimer cut their price target on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a research note on Monday, December 29th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $16.17.

Varex Imaging Stock Performance

Shares of VREX opened at $13.52 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.83 and a current ratio of 3.89. The stock has a 50-day moving average of $12.96 and a two-hundred day moving average of $11.81. The stock has a market cap of $566.49 million, a P/E ratio of -8.24 and a beta of 0.90. Varex Imaging has a one year low of $6.76 and a one year high of $14.56.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.05. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.The firm had revenue of $209.60 million during the quarter, compared to analysts’ expectations of $207.83 million. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. As a group, research analysts predict that Varex Imaging will post 0.53 EPS for the current year.

Institutional Investors Weigh In On Varex Imaging

Hedge funds have recently modified their holdings of the company. Assenagon Asset Management S.A. raised its holdings in Varex Imaging by 166.4% in the 3rd quarter. Assenagon Asset Management S.A. now owns 296,128 shares of the company’s stock worth $3,672,000 after purchasing an additional 184,959 shares during the period. Bailard Inc. acquired a new stake in Varex Imaging in the third quarter valued at approximately $479,000. Rice Hall James & Associates LLC increased its position in shares of Varex Imaging by 20.8% in the third quarter. Rice Hall James & Associates LLC now owns 909,261 shares of the company’s stock valued at $11,275,000 after buying an additional 156,289 shares in the last quarter. Acadian Asset Management LLC raised its stake in shares of Varex Imaging by 131.0% during the 2nd quarter. Acadian Asset Management LLC now owns 252,552 shares of the company’s stock worth $2,184,000 after buying an additional 143,231 shares during the period. Finally, JB Capital Partners LP lifted its position in shares of Varex Imaging by 168.2% during the 2nd quarter. JB Capital Partners LP now owns 295,000 shares of the company’s stock valued at $2,558,000 after buying an additional 185,000 shares in the last quarter.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.